Public Health England’s troubled trail

@article{Gornall2015PublicHE,
  title={Public Health England’s troubled trail},
  author={Jonathan Gornall},
  journal={BMJ : British Medical Journal},
  year={2015},
  volume={351}
}
  • J. Gornall
  • Published 3 November 2015
  • Medicine
  • BMJ : British Medical Journal
The handling of evidence for its controversial report on e-cigarettes adds to questions about the credibility of the organisation’s advice, finds Jonathan Gornall 

Controversial from creation to disbanding, via e-cigarettes and alcohol: an obituary of Public Health England

The (first) fall guy for the UK’s covid response was hamstrung by its lack of independence from government. Richard Vize charts its highs, lows, and ultimate downfall

Should e-cigarettes be licensed as medicines?

As the UK announces support for medicinal licensing of e-cigarettes, Nicholas S Hopkinson argues that this will give doctors another means to help smokers quit. But Jørgen Vestbo, Andrew Bush, and

2015: a year in review

  • S. Arie
  • Medicine
    BMJ : British Medical Journal
  • 2015
Sophie Arie looks back at some of the journal’s most important and widely read articles of 2015.

E-Cigarettes: A Disruptive Technology? An Analysis of Health Actors’ Positions on E-Cigarette Regulation in Scotland

Debates on e-cigarette regulation cast a light upon differences in thinking about appropriate approaches to health policy development within the public health community, and constructive debates on these divisive issues among health-focused actors will be a crucial step toward advancing public health.

Conflicts of Interest in E‐Cigarette Research: A Public Good and Public Interest Perspective

How legitimate researchers can square their expert opinion with validating tobacco industry-funded research is considered, given the perfidy of the tobacco industry and paucity of robust, conclusive evidence on the public health impacts of liberalizing e-cigarette use.

World No Tobacco Day - what's in it for us?

  • J. VestboC. Pisinger
  • Medicine
    American journal of physiology. Lung cellular and molecular physiology
  • 2020
This research presents a novel and scalable approach called “informed decision-based decision-making” that aims to provide real-time information about the progression of disease in mice and its effects on survival and quality.

A rational approach to e-cigarettes: challenging ERS policy on tobacco harm reduction

The current ERS Tobacco Control Committee statement rejecting harm reduction does not reflect the state of evidence around the effectiveness and safety of e-cigarettes and may be harmful if implemented.

A rational approach to e-cigarettes: challenging ERS policy on tobacco harm reduction

ERS argues that including e-cigarettes in a harm reduction strategy is not evidence-based and may result in harm, and should support access to evidence- based smoking cessation methods.

Electronic cigarettes: an aid in smoking cessation, or a new health hazard?

  • K. Farsalinos
  • Medicine, Political Science
    Therapeutic advances in respiratory disease
  • 2018
This analysis presents a brief overview of currently available evidence and gaps in research covering three main factors determine the public health impact of electronic cigarettes: their safety/risk profile, both relative to smoking and in absolute terms.

European Public Health News.

In this European Public Health News, the need for a common approach from the individual, from the health care worker,From the politician and from the community is addressed, as well as the importance of understanding the cultural context to deliver public health to refugees.

References

SHOWING 1-10 OF 46 REFERENCES

Where’s the evidence for NHS health checks?

The NHS in England must now offer health checks to swathes of the adult population. But is this programme really clinically or cost effective? asks Margaret McCartney

Evidence about electronic cigarettes: a foundation built on rock or sand?

Public Health England recently endorsed the use of e-cigarettes as an aid to quitting smoking, but the evidence on safety and efficacy underpinning the recommendations is questioned.

Why e-cigarettes are dividing the public health community

  • J. Gornall
  • Medicine
    BMJ : British Medical Journal
  • 2015
The tobacco industry used to be seen as the enemy of public health, but the move into e-cigarettes and harm reduction has seen some experts shift their views. Are they right or does industry have

Time to question the NHS diabetes prevention programme

Public Health England’s focus on individual behaviour change is unlikely to stem the epidemic of type 2 diabetes, according to a report from Public Health England.

Public Health England’s draft report on shale gas extraction

Mistaking best practices for actual practices is a mistake that can have serious consequences for both the quality and quantity of services provided and the quality of the services provided.

E-cigarettes: the best and the worst case scenarios for public health—an essay by Simon Chapman

  • S. Chapman
  • Political Science
    BMJ : British Medical Journal
  • 2014
Simon Chapman reflects on two possible long term patterns of use and argues that the authors must not repeat the mistakes with the way in which tobacco was sold and marketed.

Drug harms in the UK: a multicriteria decision analysis

The impact of NHS Health Checks on the prevalence of disease in general practices: a controlled study.

In practices providing NHS Health Checks, the change in the reported prevalence of diabetes, hypertension, CHD, CKD, and AF did not differ from that of practices providing usual care, and regression analysis did not demonstrate any significant association between the proportion of the eligible population of a practice having completed NHS Health checks and changes in the prevalence of the five conditions studied.

E-cigarettes: an evidence update. A report commissioned by Public Health England.

There is no evidence that EC are undermining the long-term decline in cigarette smoking among adults and youth, and may in fact be contributing to it, and new regulations currently planned should also maximise the public health opportunities of EC.